Request Free Sample ×
UK Medical Tourism Market Research Report — Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Medical Tourism Market

ID: MRFR/MED/42413-HCR
200 Pages
Satyendra Maurya
Last Updated: April 06, 2026

UK Medical Tourism Market Research Report: Size, Share, Trend Analysis By Types Outlook (Orthopedic/Spine Treatments, Oncology/Cancer Treatments, Cosmetic Treatments, Cardiovascular Treatments, Dental Treatments, Fertility/IVF Treatments, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Medical Tourism Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Treatment Type (USD Million)
  49.     4.1.1 Surgical Procedures
  50.     4.1.2 Dental Procedures
  51.     4.1.3 Fertility Treatments
  52.     4.1.4 Cosmetic Procedures
  53.     4.1.5 Weight Loss Procedures
  54.   4.2 Pharmaceutical, BY Service Type (USD Million)
  55.     4.2.1 Travel Services
  56.     4.2.2 Accommodation Services
  57.     4.2.3 Medical Services
  58.     4.2.4 Insurance Services
  59.     4.2.5 Wellness Services
  60.   4.3 Pharmaceutical, BY Patient Demographics (USD Million)
  61.     4.3.1 Domestic Patients
  62.     4.3.2 International Patients
  63.     4.3.3 Elderly Patients
  64.     4.3.4 Travelers Seeking Wellness
  65.     4.3.5 Patients Seeking Specialized Treatments
  66.   4.4 Pharmaceutical, BY Funding Source (USD Million)
  67.     4.4.1 Self-Payment
  68.     4.4.2 Health Insurance
  69.     4.4.3 Government Programs
  70.     4.4.4 Employer-Sponsored Programs
  71.     4.4.5 Medical Credit Financing
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Pharmaceutical
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 Bumrungrad International Hospital (TH)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 Apollo Hospitals (IN)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 Fortis Healthcare (IN)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 KPJ Healthcare Berhad (MY)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 NMC Health (AE)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Bangkok Hospital (TH)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 Cleveland Clinic (US)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 MediGence (IN)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.     5.2.9 Healthbase (US)
  137.       5.2.9.1 Financial Overview
  138.       5.2.9.2 Products Offered
  139.       5.2.9.3 Key Developments
  140.       5.2.9.4 SWOT Analysis
  141.       5.2.9.5 Key Strategies
  142.   5.3 Appendix
  143.     5.3.1 References
  144.     5.3.2 Related Reports
  145. 6 LIST OF FIGURES
  146.   6.1 MARKET SYNOPSIS
  147.   6.2 UK MARKET ANALYSIS BY TREATMENT TYPE
  148.   6.3 UK MARKET ANALYSIS BY SERVICE TYPE
  149.   6.4 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
  150.   6.5 UK MARKET ANALYSIS BY FUNDING SOURCE
  151.   6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
  152.   6.7 RESEARCH PROCESS OF MRFR
  153.   6.8 DRO ANALYSIS OF PHARMACEUTICAL
  154.   6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  155.   6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  156.   6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  157.   6.12 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 (% SHARE)
  158.   6.13 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
  159.   6.14 PHARMACEUTICAL, BY SERVICE TYPE, 2024 (% SHARE)
  160.   6.15 PHARMACEUTICAL, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
  161.   6.16 PHARMACEUTICAL, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
  162.   6.17 PHARMACEUTICAL, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
  163.   6.18 PHARMACEUTICAL, BY FUNDING SOURCE, 2024 (% SHARE)
  164.   6.19 PHARMACEUTICAL, BY FUNDING SOURCE, 2024 TO 2035 (USD Million)
  165.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  166. 7 LIST OF TABLES
  167.   7.1 LIST OF ASSUMPTIONS
  168.     7.1.1
  169.   7.2 UK MARKET SIZE ESTIMATES; FORECAST
  170.     7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
  171.     7.2.2 BY SERVICE TYPE, 2025-2035 (USD Million)
  172.     7.2.3 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
  173.     7.2.4 BY FUNDING SOURCE, 2025-2035 (USD Million)
  174.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  175.     7.3.1
  176.   7.4 ACQUISITION/PARTNERSHIP
  177.     7.4.1

UK Pharmaceutical Market Segmentation

Pharmaceutical By Treatment Type (USD Million, 2025-2035)

  • Surgical Procedures
  • Dental Procedures
  • Fertility Treatments
  • Cosmetic Procedures
  • Weight Loss Procedures

Pharmaceutical By Service Type (USD Million, 2025-2035)

  • Travel Services
  • Accommodation Services
  • Medical Services
  • Insurance Services
  • Wellness Services

Pharmaceutical By Patient Demographics (USD Million, 2025-2035)

  • Domestic Patients
  • International Patients
  • Elderly Patients
  • Travelers Seeking Wellness
  • Patients Seeking Specialized Treatments

Pharmaceutical By Funding Source (USD Million, 2025-2035)

  • Self-Payment
  • Health Insurance
  • Government Programs
  • Employer-Sponsored Programs
  • Medical Credit Financing

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓